Research Radboud technology centers Radboud Biobank News BBMRI-NL series on sustainable biobanking
25 February 2020

To become sustainable, a biobank must balance its financial, social, and operational dimensions. Despite increased interest in the topic over the past ten years, effective strategies for sustainable biobanking are remain elusive Given that each biobank is inherently unique, one-size-fits-all solutions are challenging to implement. BBMRI-NL has made a series on sustainable biobanking, combining current knowledge from literature, workshops, and focus groups. The series contains an infographic with nine recommendations to make biobanks more sustainable; it includes additional practical tools, examples, and background information. Through this series, BBMRI-NL aims to provide support and inspiration for biobanks to help them find solutions that fit their individual situation. Moreover, as greater knowledge and attention is given to issues of sustainability, the field of biobanking will undoubtedly benefit.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


Dutch-Nordic Alliance for Precision Cancer Medicine launched

26 November 2021

The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.

read more

New Automated PBMC isolation method introduced in LMI.

21 September 2021

The Radboud Biobank (RB) and the laboratory of Medical Immunology (LMI) are making plans to replace the density gradient centrifugation method with a new automated PBMC isolation method, the AutoMACS Pro Separator.

read more

Health-RI, geared up to accelerate

21 September 2021

The Dutch cabinet has selected Health-RI's National Growth Fund proposal for a national health data infrastructure. On 5 October, the kick-off will take place during a live meeting in Jaarbeurs Media Plaza in Utrecht.

read more

SUNRISE-CRC sub-biobank

21 September 2021

The main purpose of SUNRISE-CRC is to determine whether treatment with a high dose of sunitinib provides a better chance of survival and slows the progression of (colo)rectal cancer (CRC) more than standard treatment with TAS-102.

read more

PRECISE sub-biobank

21 September 2021

The aim of the PRECISE biobank is to develop the first, smart multi-modal liquid biopsy test service for the prediction of immune checkpoint inhibitor response in urothelial cancer (UC) patients – the PRECISE IVD.

read more

Lysine Metabolism sub-biobank

21 September 2021

Hereditary metabolic disorders form a large group of more than 1,400 rare disorders in which an error in the DNA causes abnormalities in the process in which proteins, fats and carbohydrates are converted into smaller building materials and energy.

read more